TLP Group’s Kyntra Bio KYNB Stock Holding History

TLP Group’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-208	Closed	-$108K	–	305
2016 Q3	$108K	Buy	+208	New	+$98K	0.11%	211

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

TLP Group's KYNB Position: Q4 2016 in Review

TLP Group sold out of Kyntra Bio (KYNB) in Q4 2016, closing a stake of 208 shares — an estimated $108K sold.

TLP Group first reported a position in KYNB in Q3 2016 and held it in 1 quarter. The position peaked at $108K in Q3 2016. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

TLP Group reported no remaining Kyntra Bio position as of Q4 2016 after selling out during the quarter.
TLP Group sold 208 Kyntra Bio shares in Q4 2016, an estimated $108K.
TLP Group first reported a position in Kyntra Bio in Q3 2016 and held it in 1 quarter.
TLP Group's Kyntra Bio position peaked at $108K in Q3 2016.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.